Latest pulmonary fibrosis Stories
Expert from the University of California San Francisco, regarded as one the world's leading academic centers in health sciences, will lead a discussion on pulmonary fibrosis in scleroderma.
First FDA Approved Treatments in United States for Devastating Lung Disease Affecting More than 200,000 Americans, with Survival Rate of Just Three to Five Years CHICAGO, Oct.
FLINT, Mich., Oct.
-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct.
-- Survey Data Requested by FDA for the September 26 Patient-Focused Drug Development Meeting for Idiopathic Pulmonary Fibrosis CHICAGO, Sept.
RIDGEFIELD, Conn., Sept.
For U.S. Media Only RIDGEFIELD, Conn., Sept.
Mayor Rahm Emanuel declares September Global Pulmonary Fibrosis Awareness Month in Chicago--the Pulmonary Fibrosis Foundation sponsors events to enhance disease awareness and provides patient and caregiver
-- Roche to acquire InterMune for $74.00 per share -- BASEL, Switzerland, Aug. 24, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc.
New data will be reported to FDA at patient-focused drug development meeting on 9/26; insights will help future PFF programs and services CHICAGO, Aug.
- A young chicken: also used as a pet name for children.